[HTML][HTML] Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles

L Kumar, MS Reddy, RS Managuli, G Pai - Saudi Pharmaceutical Journal, 2015 - Elsevier
High performance liquid chromatographic method was optimized, developed and validated
as per the ICH guidelines. In this study the 20 mM ammonium formate and acetonitrile in the …

Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan

A Bajaj, MRP Rao, A Pardeshi, D Sali - AAPS pharmscitech, 2012 - Springer
Telmisartan is an orally active nonpeptide angiotensin II receptor antagonist used in the
management of hypertension. It is a Biopharmaceutics Classification System class II drug …

Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study

S Gora, G Mustafa, JK Sahni, J Ali, S Baboota - Drug Delivery, 2016 - Taylor & Francis
Purpose: The purpose of the present study was to formulate and evaluate nanosuspension
of Valsartan (VAL), a poorly water soluble and low bioavailable drug (solubility of 0.18 mg …

[HTML][HTML] Simultaneous determination of valsartan and hydrochlorothiazide in tablets by RP-HPLC

DF Tian, XL Tian, T Tian, ZY Wang… - Indian journal of …, 2008 - ncbi.nlm.nih.gov
A simple, reproducible and efficient reverse phase high performance liquid chromatographic
method was developed for simultaneous determination of valsartan and hydrochlorothiazide …

Preparation and statistical optimization of Losartan Potassium loaded nanoparticles using Box Behnken factorial design: Microreactor precipitation

P Patil, G Khairnar, J Naik - Chemical Engineering Research and Design, 2015 - Elsevier
The current study deals with the development and optimization of Losartan Potassium (LP)
loaded nanoparticles by continuous flow microreactor precipitation methodology for …

Uniform nano-sized valsartan for dissolution and bioavailability enhancement: influence of particle size and crystalline state

Q Ma, H Sun, E Che, X Zheng, T Jiang, C Sun… - International journal of …, 2013 - Elsevier
The central purpose of this study was to evaluate the impact of drug particle size and
crystalline state on valsartan (VAL) formulations in order to improve its dissolution and …

Preparation of Candesartan and Atorvastatin Nanoparticles by Solvent Evaporation

E Vaculikova, V Grunwaldova, V Kral, J Dohnal… - Molecules, 2012 - mdpi.com
The solubility, absorption and distribution of a drug are involved in the basic aspects of oral
bioavailability Solubility is an essential characteristic and influences the efficiency of the …

[PDF][PDF] Valsartan loaded solid lipid nanoparticles: development, characterization and in vitro and ex vivo evaluation

B Parmar, S Mandal, KC Petkar, LD Patel… - Int J Pharm Sci …, 2011 - researchgate.net
Valsartan is an antihypertensive drug with poor oral bioavailability ranging from 10-35%
because of poor solubility, dissolution and most importantly, extensive first pass hepatic …

Stability Indicating RP‐HPLC Method for Determination of Valsartan in Pure and Pharmaceutical Formulation

SK Patro, SK Kanungo, VJ Patro… - Journal of …, 2010 - Wiley Online Library
A simple, rapid and accurate and stability indicating RP‐HPLC method was developed for
the determination of valsartan in pure and tablet forms. The method showed a linear …

[引用][C] RP-HPLC method for determination of valsartan in tablet dosage form

DU Vinzuda, GU Sailor, NR Sheth - Int J Chem Tech Res, 2010